AC Immune SA (ACIU)

AC Immune Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.76	26.8	36.28	78.49	31.59	82.22
Short-Term Investments	47.6	64.62	129.21	24.55	91	116
Cash & Short-Term Investments	75.36	91.41	165.49	103.05	122.59	198.22
Cash Growth	-40.73%	-44.76%	60.59%	-15.94%	-38.16%	-12.25%
Accounts Receivable	10.13	0.36	1.1	15.05	0.41	0.98
Other Receivables	3.51	0.32	0.42	0.3	0.37	0.43
Receivables	13.65	0.68	1.51	15.35	0.78	1.4
Prepaid Expenses	4.4	3.97	4.3	6.44	4.71	3.02
Other Current Assets	-	0.66	0.69	0.32	0.02	-
Total Current Assets	93.4	96.72	171.99	125.15	128.09	202.63
Property, Plant & Equipment	6	6.53	8.09	6.88	7.07	8.03
Other Intangible Assets	50.42	50.42	50.42	50.42	50.42	50.42
Other Long-Term Assets	0.59	0.58	0.42	0.36	0.36	0.36
Total Assets	150.4	154.25	230.91	182.81	185.94	261.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.51	2.07	2.66	1.68	0.93	2
Accrued Expenses	7.12	7.78	12.1	11.09	9.42	16.74
Current Portion of Leases	0.84	0.85	1.03	0.67	0.55	0.57
Current Unearned Revenue	90.77	83.71	85.06	0.14	0.59	0.72
Other Current Liabilities	-	0.29	-	-	-	-
Total Current Liabilities	100.24	94.69	100.84	13.58	11.48	20.03
Long-Term Leases	3.27	3.69	4.4	2.83	2.25	2.34
Long-Term Unearned Revenue	2.64	2.34	4.56	-	-	-
Pension & Post-Retirement Benefits	9.09	8.65	8.84	5.77	3.21	7.1
Total Liabilities	115.23	109.37	118.64	22.17	16.95	29.46

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.26	2.25	2.23	2.09	1.8	1.79
Additional Paid-In Capital	483.55	481.86	478.51	474.91	431.32	431.25
Retained Earnings	-450.44	-439.02	-368.24	-316.2	-264.02	-200.94
Treasury Stock	-0.21	-0.22	-0.22	-0.11	-0.12	-0.12
Comprehensive Income & Other	0.01	0.01	-0.01	-0.05	0.01	-
Shareholders' Equity	35.17	44.88	112.27	160.64	168.99	231.98
Total Liabilities & Equity	150.4	154.25	230.91	182.81	185.94	261.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.1	4.54	5.43	3.5	2.8	2.91
Net Cash (Debt)	71.26	86.87	160.06	99.55	119.79	195.31
Net Cash Growth	-41.70%	-45.73%	60.78%	-16.89%	-38.67%	-12.68%
Net Cash Per Share	0.70	0.86	1.61	1.18	1.43	2.61
Filing Date Shares Outstanding	99.43	99.2	98.94	93.95	77.41	77.26
Total Common Shares Outstanding	99.43	101.74	100.41	93.95	77.41	77.26
Working Capital	-6.84	2.03	71.16	111.58	116.61	182.61
Book Value Per Share	0.35	0.44	1.12	1.71	2.18	3.00
Tangible Book Value	-15.25	-5.53	61.85	110.23	118.58	181.56
Tangible Book Value Per Share	-0.15	-0.05	0.62	1.17	1.53	2.35
Machinery	14.29	13.81	13.26	12.71	11.96	11.16
Construction In Progress	-	-	-	-	0	0.7
Leasehold Improvements	1.9	1.89	1.86	1.66	1.64	0.81

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error